APA (7th ed.) Citation

SA, T. D., AA, G., K, Y., R, A. F., CT, S., K, G., . . . JR, U. (2023). The Antipsychotic Dopamine 2 Receptor Antagonist Diphenylbutylpiperidines Improve Glycemia in Experimental Obesity by Inhibiting Succinyl-CoA: 3-Ketoacid CoA Transferase. Diabetes, 72(1), 126. https://doi.org/10.2337/db22-0221

Chicago Style (17th ed.) Citation

SA, Tabatabaei Dakhili, et al. "The Antipsychotic Dopamine 2 Receptor Antagonist Diphenylbutylpiperidines Improve Glycemia in Experimental Obesity by Inhibiting Succinyl-CoA: 3-Ketoacid CoA Transferase." Diabetes 72, no. 1 (2023): 126. https://doi.org/10.2337/db22-0221.

MLA (9th ed.) Citation

SA, Tabatabaei Dakhili, et al. "The Antipsychotic Dopamine 2 Receptor Antagonist Diphenylbutylpiperidines Improve Glycemia in Experimental Obesity by Inhibiting Succinyl-CoA: 3-Ketoacid CoA Transferase." Diabetes, vol. 72, no. 1, 2023, p. 126, https://doi.org/10.2337/db22-0221.